Oliver J. Lopena

Jul 25, 2024 | dovepress.com | Martha Sajatovic |Oliver J. Lopena |Karen Johnston |Monica Doring

Back to Journals » Neuropsychiatric Disease and Treatment » Volume 20 Authors Sajatovic M, Doring M, Lopena OJ, Johnston K, Turkoz I , Josiah N, Obando C Received 25 July 2024 Accepted for publication 1 November 2024 Published 21 November 2024 Volume 2024:20 Pages 2227—2235 DOI https://doi.org/10.2147/NDT.S427227 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Taro Kishi Martha Sajatovic,1 Monica Doring,2 Oliver J...

Sep 25, 2023 | psychiatrist.com | Larry Alphs |Martha Sajatovic |Ibrahim Turkoz |Oliver J. Lopena

ABSTRACTObjective: To assess the efficacy and safety of paliperidone palmitate (PP) long-acting injectable antipsychotic (LAI) versus oral antipsychotic (OAP) treatment in adult patients diagnosed with schizophrenia (per DSM-IV or DSM-5 criteria) and varying duration of illness (0–3 years and > 3 years). Methods: Patient-level data from the PRIDE, PROSIPAL, and DREaM studies were included in a post hoc analysis.